PI
-
The INVENT COVID trial: a structured protocol for a randomized controlled trial investigating the efficacy and safety of intravenous imatinib mesylate (Impentri®) in subjects with acute respiratory distress syndrome induced by COVID-19
Atmowihardjo, L., Schippers, J. R., Bartelink, I. H., Bet, P. M., van Rein, N., Purdy, K., Cavalla, D., Comberiati, V., McElroy, A., Snape, S. D., Bogaard, H. J., Heunks, L., Juffermans, N., Schultz, M., Tuinman, P. R., Bos, L. D. J. & Aman, J., Dec 2022, In: Trials. 23, 1, p. 158 158.Research output: Contribution to journal › Article* › Academic › peer-review
-
Epigenetic Modification of the von Willebrand Factor Promoter Drives Platelet Aggregation on the Pulmonary Endothelium in Chronic Thromboembolic Pulmonary Hypertension
Manz, X. D., Szulcek, R., Pan, X., Symersky, P., Dickhoff, C., Majolée, J., Kremer, V., Michielon, E., Jordanova, E. S., Radonic, T., Bijnsdorp, I. V., Piersma, S. R., Pham, T. V., Jimenez, C. R., Noordegraaf, A. V., de Man, F. S., Boon, R. A., Voorberg, J., Hordijk, P. L., Aman, J. & 1 others, , 1 Apr 2022, In: American Journal of Respiratory and Critical Care Medicine. 205, 7, p. 808-818 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Long-term clinical outcomes of COVID-19 patients treated with imatinib
CounterCOVID Collaborative Group, 1 Apr 2022, In: The Lancet Respiratory Medicine. 10, 4, p. e34-e35Research output: Contribution to journal › Comment/Letter to the editor* › Academic
- All publications